Spironolactone causes a rapid down regulation of sigma recognition sites in guinea pig brain and liver

Neuropharmacology. 1991 Aug;30(8):923-5. doi: 10.1016/0028-3908(91)90128-x.

Abstract

The effect of dosing guinea pigs with spironolactone (100 mg/kg twice daily for 3 days) upon the sigma recognition site labelled with [3H]-DTG was investigated. Animals were dosed with 100 mg/kg spironolactone twice a day for 3 days. Spironolactone treatment caused a decrease in sigma radioligand binding in membranes prepared from liver and brain but not in adrenals or testes. Saturation analysis of [3H]-DTG radioligand binding in the brain indicated that the decrease in specifically bound [3H]-DTG binding was due to a reduction in receptor number with no change in affinity. This method for the selective depletion of brain and liver sigma recognition sites will provide a useful tool for exploring the functional significance of this site.

MeSH terms

  • Adrenal Glands / drug effects
  • Adrenal Glands / metabolism
  • Animals
  • Binding Sites
  • Brain / drug effects
  • Brain / metabolism
  • Down-Regulation
  • Guanidines / metabolism
  • Guinea Pigs
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Receptors, Opioid / drug effects
  • Receptors, Opioid / metabolism*
  • Receptors, sigma
  • Spironolactone / administration & dosage
  • Spironolactone / pharmacology*
  • Testis / drug effects
  • Testis / metabolism

Substances

  • Guanidines
  • Receptors, Opioid
  • Receptors, sigma
  • Spironolactone
  • 1,3-ditolylguanidine